Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Glaukos Corporation, 3 years.
Glaukos Corporation
Director
Celldex Therapeutics Inc.
Director
Seaport Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2026 | Glaukos Corporation | Grant or award | +1,878 | — | — |
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +13,406 | — | — |
| Jan 2, 2026 | Glaukos Corporation | Grant or award | +623 | — | — |
| May 29, 2025 | Glaukos Corporation | Grant or award | +2,108 | — | — |
| Jan 2, 2025 | Glaukos Corporation | Grant or award | +461 | — | — |
| May 30, 2024 | Glaukos Corporation | Grant or award | +1,716 | — | — |
| Jan 2, 2024 | Glaukos Corporation | Grant or award | +895 | — | — |
| Jun 1, 2023 | Glaukos Corporation | Grant or award | +3,230 | — | — |
| Jan 3, 2023 | Glaukos Corporation | Grant or award | +1,572 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.